Skip to main content
Onikepe Adegbola, MD, Radiology, King of Prussia, PA

Onikepe Adegbola MD PhD

Radiology•King of Prussia, PA

Nuclear Medicine

Chief Medical Officer, Molecular Imaging Executive Medical Director - GE Healthcare

Join to view full profile

  • 170 N Henderson RdSte 310King of Prussia, PA 19406

  • Phone+1 610-486-5870

  • Fax+1 610-298-9147

Dr. Adegbola is on Doximity

As a Doximity member, you’ll join more than three million U.S. healthcare professionals—including 85+% of physicians, and 2/3 of all NPs and PAs—in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.
See Dr. Adegbola's full profileAlready have an account?

Summary

  • Dr. Onikepe Adegbola, based in Philadelphia, PA, is a radiologist with a subspecialty in nuclear medicine. She completed her medical education at the University of Lagos College of Medicine in 1995, followed by a residency in pathology at New York Presbyterian Hospital and a fellowship in nuclear medicine at the University of Pennsylvania Health System. Dr. Adegbola also holds a PhD in pathobiology with a focus on cancer biology from The Johns Hopkins University. Her professional roles include serving as Chief Medical Officer and Executive Medical Director at GE Healthcare since 2010. She has previous experience as Medical Director at Bayer HealthCare Pharmaceuticals and as Imaging Project Leader at Novartis Pharmaceuticals. Dr. Adegbola’s work has focused on molecular and diagnostic imaging, particularly in lymphoma. She has authored several publications, including a highly cited study on mTOR and P70 S6 Kinase in liver neoplasms. Her accolades include a UNCF Merck Fellowship and multiple honors from Johns Hopkins.

Education & Training

  • Cornell University – Johnson Graduate School Of Management
    Cornell University – Johnson Graduate School Of ManagementExecutive Education, 2013 - 2013
  • University of Pennsylvania Health System
    University of Pennsylvania Health SystemFellowship, Nuclear Medicine, 2005 - 2007
  • Johns Hopkins University School of Medicine
    Johns Hopkins University School of MedicinePhD, Pathobiology; Concentration in Cancer Biology, 2005 - 2005
  • University of California, San Francisco
    University of California, San FranciscoPost-Doctoral Fellowship, 2000 - 2001
  • New York Presbyterian Hospital (Columbia Campus)
    New York Presbyterian Hospital (Columbia Campus)Residency, Pathology-Anatomic and Clinical, 1998 - 2000

Certifications & Licensure

  • FL State Medical License
    FL State Medical License 2025 - Present
  • WA State Medical License
    WA State Medical License 2026 - 2028
  • CT State Medical License
    CT State Medical License 2007 - 2027
  • PA State Medical License
    PA State Medical License 2009 - 2026

Awards, Honors, & Recognition

  • UNCF Merck Fellowship 2004
  • Honorable Mention, L’Oreal Women in Science Fellowship 2004
  • Johns Hopkins Department of Pathology Young Investigator Day award 2003, 2004, 2004

Publications & Presentations

PubMed

Journal Articles

  • Molecular Imaging in Clinical Trials.  
    Adegbola, O., and Conti, P., Springer

Abstracts/Posters

  • Comparability of quantitative SUV measurement between PET alone and PET-CT on patients scanned consecutively on PET and PET-CT scanners.
    M. Bathaii, J.R. Saffer, P.H. Tang, J. Karp, O. Adegbola, L. Loevner, A. Alavi, SNM meeting
  • A pp32 - Rb complex modulates androgen receptor-dependent transcription and associates with components of the splicing machinery.
    Adegbola, O., Pasternack, G.R., Biochem Biophys Res Commun; 334(2):702-8

Lectures

  • Enhancing Imaging Techniques and Technologies to Streamline Drug Development. 
    Translational Imaging in Drug Development, London, UK
  • Strategies to Facilitate Translational Imaging in Drug Development. 
    2nd Imaging in Drug Development, London, UK
  • Exploratory Imaging in Drug Development - Cost Analysis and Resource Requirements. 
    Annual Medical Imaging for Clinical Trials, Arlington, VA

Other

  • Control of proliferation and apoptosis in cancer cells. 
    Pasternack, G.R., Adegbola, O. and The Johns Hopkins University School of Medicine, U.S. Provisional 11/413,082
  • Annotation of the Genome of Candida albicans. 
    Dungan J, Kuo A, Newport G, Lan C-Y, Iijima,C, Adegbola O, Roberts J, Persson K, Donnelly S, Favoreto S, Tzung K-W, Jones T, Scherer S. and Agabian N, Update to the NCBI Entrez Nucleotide Accession AACQ00000000
    http://www.ncbi.nlm.nih.gov/entrez/viewer.fcgi?val=AACQ00000000

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence:

Dr. Onikepe Adegbola, Dr. Onikepe Adegbola, MD, Dr. O Adegbola